Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Clinical trial NCT07281014 · RECRUITING
Trial details
- NCT number
- NCT07281014
- Sponsor
- Yale University
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-27
- Primary completion
- 2027-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.